Intrathecal or Intraventricular Infusion of Rituximab for Children with B-cell Lymphoid Malignancies and Central Nervous System Disease

Sekimizu Masahiro; Osumi Tomoo

首页> 外文期刊>Pediatric blood & cancer >Intrathecal or Intraventricular Infusion of Rituximab for Children with B-cell Lymphoid Malignancies and Central Nervous System Disease

【24h】

Intrathecal or Intraventricular Infusion of Rituximab for Children with B-cell Lymphoid Malignancies and Central Nervous System Disease

机译：用于患有B细胞淋巴恶恶性肿瘤和中枢神经系统疾病的儿童的Rituximab的鞘内或脑内输注

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s5期|共1页
作者
Sekimizu Masahiro; Osumi Tomoo;
展开▼
作者单位

Natl Hosp Org Nagoya Med Ctr Dept Pediat Nagoya Aichi Japan;

Natl Ctr Child Hlth &

Dev Childrens Canc Ctr Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Intrathecal or Intraventricular Infusion of Rituximab for Children with B-cell Lymphoid Malignancies and Central Nervous System Disease [J] . Sekimizu Masahiro, Osumi Tomoo Pediatric blood & cancer . 2019,第S5期

机译：用于患有B细胞淋巴恶恶性肿瘤和中枢神经系统疾病的儿童的Rituximab的鞘内或脑内输注
2. Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review [J] . Archives of disease in childhood . 2020,第7期

机译：中枢神经系统预防促进大型B细胞淋巴瘤患者独立鞘内化疗的疗效，促进基于蒽环类化疗治疗的弥漫性大B细胞淋巴瘤患者：系统评价
3. Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review [J] . Toby A. Eyre, Faouzi Djebbari, Amy A. Kirkwood, Haematologica . 2020,第7期

机译：中枢神经系统预防促进在Rituximab时代蒽环类化疗治疗的弥漫性大B细胞淋巴瘤患者中的中枢神经系统预防弥漫性大B细胞淋巴瘤患者的疗效：系统评价
4. INTRATHECAL MAGNETIC DRUG TARGETING: A NEW APPROACH TO TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM [C] . Eric Lueshen, Indu Venugopal, Andreas Linninger ASME Global Congress on Nanoengineering for Medicine and Biology . 2013

机译：鞘内磁药靶向：一种治疗中枢神经系统疾病的新方法
5. Pharmacological Characterization of TAS05567, a Potent and Selective Inhibitor of Spleen Tyrosine Kinase, in Animal Models of Inflammatory Diseases and B-cell Malignancies [D] . 林宏明 2019

机译：TAS05567，脾酪氨酸激酶的强效和选择性抑制剂，在炎症性疾病和B细胞恶性动物模型中的药理特性
6. Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review [O] . Toby A. Eyre, Faouzi Djebbari, Amy A. Kirkwood, 2020

机译：利妥昔单抗时代以蒽环类为基础的化疗治疗弥漫性大B细胞淋巴瘤患者中单独鞘内化疗预防中枢神经系统的疗效：系统评价
7. Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review [O] . Toby A. Eyre, Faouzi Djebbari, Amy A. Kirkwood, 2019

机译：中枢神经系统预防促进在Rituximab时代蒽环类化疗治疗的弥漫性大B细胞淋巴瘤患者中的中枢神经系统预防弥漫性大B细胞淋巴瘤患者的疗效：系统评价

Intrathecal or Intraventricular Infusion of Rituximab for Children with B-cell Lymphoid Malignancies and Central Nervous System Disease

著录项

相似文献

相关主题

期刊订阅